The National Independent Laboratory Association Logo
  
  • Home
  • Contact
  • Member Login
Register
  • About
  • Advocacy
    • LDTs/VALID Act
    • SALSA/PAMA
    • Advocacy Fund
    • Archived
  • News
  • Membership
    • Membership Benefits
    • Join
    • Renew
    • Vendor Members
  • Meetings
    • Lab Leaders Forum and Mid-Winter Meeting
  • AAB Homepage

FDA Releases Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus

FDA Draft Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products

Federal Register Announcement, August 17, 2016

FDA Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products, published January 2016

FDA Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), published August 8, 2007

  • News

NILA News

3/4/2025
NILA Meets for Lab Leaders Forum in San Antonio

1/8/2025
NILA's 2025 Lab Leaders Forum and Mid-Year Meeting to be Held Feb. 28-Mar. 1

10/8/2024
NILA and AAB File an Amicus Brief in Support of the ACLA and AMP Lawsuit Against FDA’s LDT Rule

   

Copyright The National Independent Laboratory Association. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • Home
  • NILA Membership
  • Search
  • Sitemap
  • Contact NILA
  • Return/Cancellation Policy
  • Privacy Policy

The National Independent Laboratory Association
906 Olive Street - Suite 1200, St. Louis, MO 63101-1448, 314-241-1445 - Fax 314-241-1449